null mutation human apoc3 confers favorable plasma lipid profile apparent cardioprotection
apolipoprotein c-iii apoc-iii inhibits triglyceride hydrolysis implicated coronary artery disease genome wide association study found % lancaster amish heterozygous carriers null mutation r19x gene encoding apoc iii apoc3 result express half amount apoc iii present noncarriers mutation carriers compared noncarriers lower fasting postprandial serum triglycerides higher levels hdl cholesterol lower levels ldl cholesterol subclinical atherosclerosis measured coronary artery calcification less common carriers noncarriers suggests lifelong deficiency apoc iii cardioprotective effect
